Home > Financial Ratios > MANKIND PHARMA

MANKIND PHARMA
EV/Net Sales

    Back to All Ratios
MANKIND PHARMA is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results

MANKIND PHARMA Last 5 Year EV/Net Sales History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   EV/Net Sales(x) 8.81-0.030.06-0.07-0.04

What is the latest EV/Net Sales ratio of MANKIND PHARMA ?

The latest EV/Net Sales ratio of MANKIND PHARMA is 8.81 based on Mar2024 Consolidated results.
Year EV/Net Sales
Mar20248.81
Mar2023-0.03
Mar20220.06
Mar2021-0.07
Mar2020-0.04

How is EV/Net Sales of MANKIND PHARMA Trending?

Years EV/Net Sales % Change
Mar2024 8.81
Positive
Mar2023 -0.03
Negative
Mar2022 0.06
Positive
Mar2021 -0.07
Negative
Mar2020 -0.04 -

Other Financial Ratios of MANKIND PHARMA


Compare EV/Net Sales ratio of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹98,303.1 Cr 1.1% -7% 9.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹405,176.0 Cr -0.3% -2.9% 11.5% Stock Analytics
DIVIS LABORATORIES ₹177,076.0 Cr 0.7% 7.4% 48.1% Stock Analytics
CIPLA ₹121,592.0 Cr -0.1% 0.2% -2.1% Stock Analytics
DR REDDYS LABORATORIES ₹113,615.0 Cr 3.2% 10.3% 11.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹110,024.0 Cr 2.3% -0.5% 13.8% Stock Analytics


MANKIND PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

1.1%

-7%

9.7%

SENSEX

-1.3%

-0.3%

5.8%


You may also like the below Video Courses